FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Workshop on Patient Experience Data

[ Price : $8.95]

Federal Register notice: FDA announces a 12/13 virtual public workshop entitled Patient-Focused Drug Development: Workshop to Disc...

Boston Scientific Recalls Cryoablation Catheters

[ Price : $8.95]

Boston Scientific recalls (Class 1) its POLARx and POLARx FIT Cryoablation Balloon Catheters because of atrio-esophageal fistula r...

LivaNova Sleep Apnea Device Meets Endpoints

[ Price : $8.95]

LivaNova says its aura6000 obstructive sleep apnea treatment met the safety and efficacy endpoints in the OSPREY trial in adults.

FDA Needs Inspection Staff Recruitment Plan: GAO

[ Price : $8.95]

GAO healthcare director Mary Denigan-Macauley says FDA needs a plan and a strategy for recruiting and retaining new facility inspe...

FDA Clears GEs Head-Only MRI Device

[ Price : $8.95]

FDA clears a GE HealthCare 510(k) for its Signa Magnus, a 3.0T high-performance, head-only MRI scanner.

QS Issues at American Contract

[ Price : $8.95]

FDA warns Mechanicsville, VA-based American Contract Systems about Quality System Regulation violations in its manufacturing of st...

CGMP Violations in Zhejiang Qimei Records Review

[ Price : $8.95]

FDA warns Chinas Zhejiang Qimei Cosmetic Co. about CGMP violations in its manufacturing of OTC drugs.

Abeona Skin Disorder BLA Resubmission Accepted

[ Price : $8.95]

FDA accepts for review an Abeona Therapeutics BLA resubmission for prademagene zamikeracel (pz-cel), a gene therapy for patients w...

Nuplazid Not Withdrawn Over Safety/Efficacy

[ Price : $8.95]

Federal Register notice: FDA determines that Nuplazid (pimavanserin tartrate) tablet (equivalent 17 mg base) was not withdrawn due...

Workshop on Optimizing Real-World Evidence Use

[ Price : $8.95]

Federal Register notice: FDA announces a 12/12 public workshop titled Optimizing the Use of Real-World Evidence in Regulatory Deci...